Increased risk for COVID ‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased risk for
COVID
‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Authors
Keywords
-
Journal
World Psychiatry
Volume 21, Issue 1, Pages 124-132
Publisher
Wiley
Online
2021-10-08
DOI
10.1002/wps.20921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
- (2021) QuanQiu Wang et al. Alzheimers & Dementia
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants
- (2021) Ezgi Hacisuleyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
- (2021) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
- (2021) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021
- (2021) Jennifer B. Griffin et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
- (2021) Ashley Fowlkes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- (2021) Catherine M. Brown et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Prevalence and Outcomes of Acute Ischemic Stroke Among Patients ≤50 Years of Age With Laboratory Confirmed COVID-19 Infection
- (2020) Frank Annie et al. AMERICAN JOURNAL OF CARDIOLOGY
- Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults
- (2020) Kimberly A. Fisher et al. ANNALS OF INTERNAL MEDICINE
- COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
- (2020) Quan Qiu Wang et al. MOLECULAR PSYCHIATRY
- Increased risk of COVID ‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
- (2020) QuanQiu Wang et al. World Psychiatry
- Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
- (2020) Stephanie L. Harrison et al. PLOS MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection
- (2020) QuanQiu Wang et al. JAMA Oncology
- When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities
- (2020) QuanQiu Wang et al. BLOOD REVIEWS
- Tailoring vaccines for older people and the very young
- (2019) Amanda Keener NATURE
- Drugs of abuse induced-subversion of the peripheral immune response and central glial activity: Focus on novel therapeutic approaches.
- (2018) Thea Magrone et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Racial/ethnic differences in 12-month prevalence and persistence of mood, anxiety, and substance use disorders: Variation by nativity and socioeconomic status
- (2018) Corrie L. Vilsaint et al. COMPREHENSIVE PSYCHIATRY
- Epidemiology ofDSM-5Drug Use Disorder
- (2016) Bridget F. Grant et al. JAMA Psychiatry
- The effect of aging of the immune system on vaccination responses
- (2013) Janet M. Lord Human Vaccines & Immunotherapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started